Cargando…
The current status of treatment for colorectal cancer in China: A systematic review
BACKGROUND: Colorectal cancer (CRC) is one of the most common cancers all over the world, but its epidemiology is obviously different in various regions. METHODS: The treatment of CRC also has varying characteristics due to differences in economy, geography, disease onset, chemotherapy, and other fa...
Autores principales: | Zhang, Yumei, Chen, Zhiyu, Li, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738019/ https://www.ncbi.nlm.nih.gov/pubmed/28984783 http://dx.doi.org/10.1097/MD.0000000000008242 |
Ejemplares similares
-
KRAS, NRAS, BRAF signatures, and MMR status in colorectal cancer patients in North China
por: Lian, Shen-Yi, et al.
Publicado: (2023) -
Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers
por: Chen, Yanglong, et al.
Publicado: (2019) -
Clinical efficacy of adjuvant chemotherapy in the treatment of pT4 stage II colorectal cancer with defective mismatch repair status: A protocol for systematic review and meta-analysis
por: Huang, Li-Bin, et al.
Publicado: (2020) -
Effect of Quxie capsule in patients with colorectal cancer: A systematic review and meta-analysis
por: Zhang, Suqin, et al.
Publicado: (2021) -
Apatinib as an optional treatment in metastatic colorectal cancer
por: Li, Aiyi, et al.
Publicado: (2019)